Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

ATAI Life Sciences Q4 EPS $(0.12) Beats $(0.16) Estimate, Sales $18.00K Miss $190.00K Estimate

Author: Benzinga Newsdesk | March 28, 2024 07:14am
ATAI Life Sciences (NASDAQ:ATAI) reported quarterly losses of $(0.12) per share which beat the analyst consensus estimate of $(0.16) by 25 percent. This is a 57.14 percent increase over losses of $(0.28) per share from the same period last year. The company reported quarterly sales of $18.00 thousand which missed the analyst consensus estimate of $190.00 thousand by 90.53 percent. This is a 52.63 percent decrease over sales of $38.00 thousand the same period last year.

Posted In: ATAI


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist